Published in Am J Respir Crit Care Med on September 15, 2014
Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One (2015) 1.59
Characterization of Electronic Cigarette Aerosol and Its Induction of Oxidative Stress Response in Oral Keratinocytes. PLoS One (2016) 1.46
Use of electronic nicotine delivery systems and other tobacco products among USA adults, 2014: results from a national survey. Int J Public Health (2015) 1.08
Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study. Ann Intern Med (2017) 1.00
Short-term effects of a nicotine-free e-cigarette compared to a traditional cigarette in smokers and non-smokers. BMC Pulm Med (2015) 0.97
Patient-physician communication regarding electronic cigarettes. Prev Med Rep (2015) 0.92
Electronic Cigarettes Efficacy and Safety at 12 Months: Cohort Study. PLoS One (2015) 0.90
The electronic cigarette: a wolf in sheep's clothing. Wien Klin Wochenschr (2015) 0.80
Early origins of chronic obstructive lung diseases across the life course. Eur J Epidemiol (2014) 0.80
The Potential That Electronic Nicotine Delivery Systems Can be a Disruptive Technology: Results From a National Survey. Nicotine Tob Res (2016) 0.80
E-cigarette use and disparities by race, citizenship status and language among adolescents. Addict Behav (2016) 0.78
The effect of potential electronic nicotine delivery system regulations on nicotine product selection. Addiction (2016) 0.78
Knowledge and Perceptions about Nicotine, Nicotine Replacement Therapies and Electronic Cigarettes among Healthcare Professionals in Greece. Int J Environ Res Public Health (2016) 0.76
Documenting the emergence of electronic nicotine delivery systems as a disruptive technology in nicotine and tobacco science. Addict Behav (2016) 0.75
High Cigarette and Poly-Tobacco Use Among Workers in a Dusty Industry: New Jersey Quarry Workers. J Occup Environ Med (2016) 0.75
Knowledge about electronic cigarettes and its perception: a community survey, Egypt. Respir Res (2016) 0.75
Electronic-cigarette Use and Respiratory Symptoms in Adolescents. Am J Respir Crit Care Med (2016) 0.75
The up-rise in e-cigarette use - friend or foe? Respir Res (2016) 0.75
Non-pharmacological management of chronic obstructive pulmonary disease. Ulster Med J (2015) 0.75
A Review of Pulmonary Toxicity of Electronic Cigarettes In The Context of Smoking: A Focus On Inflammation. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Graphical review: The redox dark side of e-cigarettes; exposure to oxidants and public health concerns. Redox Biol (2017) 0.75
The effect of telithromycin in acute exacerbations of asthma. N Engl J Med (2006) 5.35
Mechanical complications of central venous catheters. J Intensive Care Med (2006) 4.89
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis (2012) 4.62
Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med (2004) 4.58
Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59
Dr. Friedrich Wegener, the ACCP, and History. Chest (2007) 3.30
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia. Eur Respir J (2013) 2.69
Heated Humidified High-Flow Nasal Oxygen in Adults: Mechanisms of Action and Clinical Implications. Chest (2015) 2.66
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest (2009) 2.34
Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med (2006) 2.28
Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest (2004) 2.26
The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev (2003) 2.22
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J (2013) 2.20
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest (2013) 2.19
A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med (2007) 2.08
The European Respiratory Society plans its future: the 2013-2018 strategic plan. Eur Respir J (2014) 2.02
Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis (2011) 1.97
Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea. Thorax (2006) 1.95
Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax (2013) 1.92
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood (2004) 1.83
uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol (2004) 1.71
Molecular biology of lung cancer. J Thorac Dis (2013) 1.67
Can pictorial warning labels on cigarette packages address smoking-related health disparities? Field experiments in Mexico to assess pictorial warning label content. Cancer Causes Control (2012) 1.55
Assessment of severity of ICU-acquired pneumonia and association with etiology. Crit Care Med (2014) 1.53
Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J (2003) 1.52
Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.50
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis (2008) 1.49
Increased serum levels of advanced glycation end-products is associated with severity of sleep disordered breathing but not insulin sensitivity in non-diabetic men with obstructive sleep apnoea. Sleep Med (2011) 1.49
Bronchiectasis: an update. Clin Respir J (2009) 1.48
Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU. Crit Care Med (2013) 1.48
Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections. Pediatr Infect Dis J (2005) 1.47
Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol Cell Biol (2006) 1.46
Adrenomedullin refines mortality prediction by the BODE index in COPD: the "BODE-A" index. Eur Respir J (2013) 1.45
Lung Density Changes With Growth and Inflation. Chest (2015) 1.42
Tuberculosis elimination: theory and practice in Europe. Eur Respir J (2014) 1.42
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax (2013) 1.41
ICU-acquired pneumonia with or without etiologic diagnosis: a comparison of outcomes. Crit Care Med (2013) 1.41
Dr. Friedrich Wegener and the ACCP, Revisited. Chest (2007) 1.39
Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J Biol Chem (2005) 1.33
Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies. J Cell Biol (2007) 1.30
Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. Am J Respir Cell Mol Biol (2012) 1.28
A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny. Development (2005) 1.25
Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization. J Biol Chem (2002) 1.25
The urokinase receptor as an entertainer of signal transduction. Front Biosci (Landmark Ed) (2009) 1.21
Analysis of the DNA-binding profile and function of TALE homeoproteins reveals their specialization and specific interactions with Hox genes/proteins. Cell Rep (2013) 1.21
Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. J Clin Invest (2009) 1.19
Overexpression of PREP-1 in F9 teratocarcinoma cells leads to a functionally relevant increase of PBX-2 by preventing its degradation. J Biol Chem (2003) 1.19
Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursors. Mol Cell Biol (2005) 1.17
Early respiratory abnormalities in emergency services police officers at the World Trade Center site. J Occup Environ Med (2004) 1.17
Expression of Hoxa2 in rhombomere 4 is regulated by a conserved cross-regulatory mechanism dependent upon Hoxb1. Dev Biol (2006) 1.17
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest (2004) 1.17
MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood (2004) 1.15
An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. Mol Biol Cell (2005) 1.15
Hoxb1 enhancer and control of rhombomere 4 expression: complex interplay between PREP1-PBX1-HOXB1 binding sites. Mol Cell Biol (2005) 1.14
The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J Cell Sci (2004) 1.14
Improving nurse-physician communication and satisfaction in the intensive care unit with a daily goals worksheet. Am J Crit Care (2006) 1.12
Prep1.1 has essential genetic functions in hindbrain development and cranial neural crest cell differentiation. Development (2004) 1.12
Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia. J Cereb Blood Flow Metab (2012) 1.08
Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates. Dev Dyn (2013) 1.07
Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays. Nucleic Acids Res (2005) 1.07
Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism. Mol Cell Biol (2008) 1.07
Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR. PLoS One (2008) 1.06
Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. Chest (2006) 1.06
Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. Mol Cell Proteomics (2009) 1.05
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity. Dev Biol (2007) 1.05
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis (2012) 1.05
p160 Myb-binding protein interacts with Prep1 and inhibits its transcriptional activity. Mol Cell Biol (2007) 1.04
Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling. Mol Pharm (2013) 1.03
Consumption of single cigarettes and quitting behavior: a longitudinal analysis of Mexican smokers. BMC Public Health (2011) 1.03
Induction of HoxB transcription by retinoic acid requires actin polymerization. Mol Biol Cell (2009) 1.03
Multiparametric, longitudinal optical coherence tomography imaging reveals acute injury and chronic recovery in experimental ischemic stroke. PLoS One (2013) 1.02
Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor. Thromb Haemost (2002) 1.01
Prep1 directly regulates the intrinsic apoptotic pathway by controlling Bcl-XL levels. Mol Cell Biol (2008) 1.01
Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH. Respir Res (2013) 1.00
Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols. J Clin Microbiol (2002) 1.00
Cytoplasmic Prep1 interacts with 4EHP inhibiting Hoxb4 translation. PLoS One (2009) 0.99
Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care. J Antimicrob Chemother (2010) 0.99
Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function. J Bone Miner Res (2007) 0.99
Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis (2002) 0.97
Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis. Proc Natl Acad Sci U S A (2014) 0.96
Executive summary: effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines. Chest (2009) 0.96
Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: an unmet need. Chest (2009) 0.96
Aetiology of acute pharyngitis: the role of atypical bacteria. J Med Microbiol (2004) 0.95
Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability. Proc Natl Acad Sci U S A (2011) 0.95
uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro. J Cell Sci (2008) 0.95
Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones. Eur Respir J (2012) 0.94
Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease. Respir Med (2004) 0.93
The absence of Prep1 causes p53-dependent apoptosis of mouse pluripotent epiblast cells. Development (2010) 0.93
Detection of respiratory viruses and atypical bacteria in children's tonsils and adenoids. J Clin Microbiol (2007) 0.93
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res (2008) 0.93
How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan. Respir Res (2012) 0.92
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes. Int J Infect Dis (2013) 0.92
Echocardiography in pulmonary arterial hypertension: An essential tool. Chest (2007) 0.92
Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. Am J Respir Crit Care Med (2015) 0.91
Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase. Diabetes (2010) 0.91
The urokinase receptor and the regulation of cell proliferation. Thromb Haemost (2005) 0.90
Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep (2008) 0.90